| P2093 | author name string | Tao Liu | |
| | Peng Xie | |
| | Ming Chang | |
| | Linsen Hu | |
| | Yihong Hu | |
| | Jinhua Piao | |
| | Yingjiu Zhang | |
| | Xing'an Li | |
| P2860 | cites work | The alternative role of 14-3-3 zeta as a sweeper of misfolded proteins in disease conditions | Q48628183 |
| | The proteomics of sickle cell disease: profiling of erythrocyte membrane proteins by 2D-DIGE and tandem mass spectrometry. | Q50747553 |
| | Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly. | Q53216133 |
| | In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies | Q64764806 |
| | Cu/Zn superoxide dismutase-like immunoreactivity is present in Lewy bodies from Parkinson disease: a light and electron microscopic immunocytochemical study | Q72064008 |
| | Cu/Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis | Q72520333 |
| | Chromatin condensation is not associated with apoptosis | Q77229025 |
| | Subcellular fractionation | Q79436481 |
| | Peptide fragment intensity statistical modeling | Q80830941 |
| | Chaperone proteins identified from synthetic proteasome inhibitor-induced inclusions in PC12 cells by proteomic analysis | Q81237748 |
| | Tubulin seeds alpha-synuclein fibril formation | Q24291881 |
| | A Product of the Human Gene Adjacent to parkin Is a Component of Lewy Bodies and Suppresses Pael Receptor-induced Cell Death | Q24297163 |
| | Parkin accumulation in aggresomes due to proteasome impairment | Q24308757 |
| | Regulation of type II collagen synthesis during osteoarthritis by prolyl-4-hydroxylases: possible influence of low oxygen levels | Q24671477 |
| | A simple technique for quantifying apoptosis in 96-well plates | Q24810168 |
| | alpha-Synuclein shares physical and functional homology with 14-3-3 proteins | Q28139698 |
| | Superoxide dismutase--applications and relevance to human diseases | Q28198204 |
| | Inhibition of proteasomes induces accumulation, phosphorylation, and recruitment of HSP27 and alphaB-crystallin to aggresomes | Q28211937 |
| | Aggresome formation and neurodegenerative diseases: therapeutic implications | Q28265926 |
| | Protein aggregation and neurodegenerative disease | Q28273600 |
| | Rat pheochromocytoma tyrosine hydroxylase is phosphorylated on serine 40 by an associated protein kinase | Q28282891 |
| | A single polypeptide acts both as the beta subunit of prolyl 4-hydroxylase and as a protein disulfide-isomerase | Q28288295 |
| | Regional assignment of the human gene coding for a multifunctional polypeptide (P4HB) acting as the β-subunit of prolyl 4-hydroxylase and the enzyme protein disulfide isomerase to 17q25 | Q28296844 |
| | ER chaperones in mammalian development and human diseases | Q28300625 |
| | Proteomic changes of PC12 cells treated with proteasomal inhibitor PSI | Q28569104 |
| | Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination | Q28570666 |
| | Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation | Q28572388 |
| | Proteomic analysis of ubiquitin-proteasome effects: insight into the function of eukaryotic initiation factor 5A | Q28586364 |
| | Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging | Q29614783 |
| | The minimum information about a proteomics experiment (MIAPE) | Q29615391 |
| | Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies. | Q30312062 |
| | A proteomic survey of rat cerebral cortical synaptosomes | Q31163203 |
| | Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells | Q33285275 |
| | An update on data standards for gel electrophoresis | Q33300248 |
| | Hepatitis B virus X protein suppressing adriamycin-induced apoptosis of HepG2 cells | Q33316883 |
| | Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson's disease | Q33318606 |
| | Specificity in intracellular protein aggregation and inclusion body formation | Q33949081 |
| | Proteasome inhibitor-induced apoptosis is mediated by positive feedback amplification of PKCdelta proteolytic activation and mitochondrial translocation | Q34214022 |
| | Tyrosine hydroxylase protein in Lewy bodies of parkinsonian and senile brains | Q42447562 |
| | Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production | Q43658583 |
| | Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells | Q43718632 |
| | Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells | Q43758292 |
| | Ubiquitination of soluble and membrane-bound tyrosine hydroxylase and degradation of the soluble form | Q43902847 |
| | Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease | Q44048965 |
| | Aggresome-related biogenesis of Lewy bodies | Q44242992 |
| | Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies | Q44295928 |
| | Effect of proteasome inhibitor on cultured mesencephalic dopaminergic neurons | Q44308146 |
| | Enhanced oligomerization of the alpha-synuclein mutant by the Cu,Zn-superoxide dismutase and hydrogen peroxide system. | Q44379856 |
| | Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function | Q44552114 |
| | Fine Structure and Biochemical Mechanisms Underlying Nigrostriatal Inclusions and Cell Death after Proteasome Inhibition | Q44605313 |
| | Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells. | Q44693092 |
| | Analysis of alpha-synuclein-associated proteins by quantitative proteomics | Q44964546 |
| | Generalized brain and skin proteasome inhibition in Huntington's disease | Q45045405 |
| | A proteasomal stress response: pre-treatment with proteasome inhibitors increases proteasome activity and reduces neuronal vulnerability to oxidative injury | Q45138331 |
| | Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases | Q45230472 |
| | VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration | Q45304146 |
| | Huntingtin inclusions do not deplete polyglutamine-containing transcription factors in HD mice | Q45305847 |
| | Angiotensin-(1-7) through AT receptors mediates tyrosine hydroxylase degradation via the ubiquitin-proteasome pathway | Q46138698 |
| | Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro-apoptotic transcriptional responses: a microarray analysis | Q46578554 |
| | Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease | Q46593989 |
| | Apoptosis and the conformational change of Bax induced by proteasomal inhibition of PC12 cells are inhibited by bcl-xL and bcl-2. | Q46679719 |
| | Ultrasonic extraction and separation of anthraquinones from Rheum palmatum L. | Q46749006 |
| | Proteasome inhibition: an early or late event in nitric oxide-induced neuronal death? | Q46851350 |
| | Proteomic identification of novel proteins in cortical lewy bodies | Q48227693 |
| | An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism | Q48352469 |
| | Potential oxidative pathways of brain catecholamines | Q48410486 |
| | Neural heme oxygenase-1 expression in idiopathic Parkinson's disease | Q48503937 |
| | Unfolding the role of chaperones and chaperonins in human disease | Q34348757 |
| | Proteasomal dysfunction in sporadic Parkinson's disease | Q34529359 |
| | Hassles with taking out the garbage: aggravating aggresomes. | Q34637179 |
| | Substrate recognition by the protein disulfide isomerases | Q34692501 |
| | How the ubiquitin-proteasome system controls transcription | Q35075758 |
| | Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease. | Q35157623 |
| | The role of the ubiquitin/proteasome system in cellular responses to radiation | Q35208807 |
| | Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy. | Q35760480 |
| | Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. | Q35869366 |
| | Roles of molecular chaperones in protein degradation | Q36236478 |
| | Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70. | Q36265331 |
| | Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease | Q36278180 |
| | Sequential assistance of molecular chaperones and transient formation of covalent complexes during protein degradation from the ER. | Q36323835 |
| | Expanding insights of mitochondrial dysfunction in Parkinson's disease. | Q36404133 |
| | Protein quality control: the who's who, the where's and therapeutic escapes | Q36432134 |
| | Protein misfolding disorders: pathogenesis and intervention | Q36501365 |
| | Mechanisms of disease II: cellular protein quality control. | Q36748835 |
| | Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery | Q37072429 |
| | Proteomic identification of novel proteins associated with Lewy bodies | Q37146740 |
| | From hatching to dispatching: the multiple cellular roles of the Hsp70 molecular chaperone machinery | Q37292909 |
| | Ubiquitin-dependent and -independent mitochondrial protein quality controls: implications in ageing and neurodegenerative diseases | Q37329440 |
| | Think locally: control of ubiquitin-dependent protein degradation in neurons | Q37349687 |
| | Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle | Q37509229 |
| | Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1. | Q38310990 |
| | Ubiquitin crosstalk connecting cellular processes | Q38702950 |
| | Mitochondria and ubiquitin-proteasomal system interplay: relevance to Parkinson's disease | Q39962524 |
| | Proteasome inhibition blocks caspase-8 degradation and sensitizes prostate cancer cells to death receptor-mediated apoptosis | Q40036325 |
| | Effects of proteasome inhibitor, MG132, on proteasome activity and oxidative status of rat liver | Q40128812 |
| | Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation | Q40212840 |
| | Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress | Q40262236 |
| | Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells | Q40395753 |
| | Identification of the ubiquitin-proteasome pathway in the regulation of the stability of eukaryotic elongation factor-2 kinase | Q40427685 |
| | Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology | Q40518177 |
| | Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. | Q40556399 |
| | Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover | Q40595923 |
| | Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of Mammalian proteasomes | Q40658264 |
| | Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein | Q40662036 |
| | Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway | Q41064925 |
| | Neuropathology of Parkinson's disease | Q41095404 |
| | Expression of K6W-ubiquitin in lens epithelial cells leads to upregulation of a broad spectrum of molecular chaperones. | Q41822888 |
| | Histone carbonylation in vivo and in vitro | Q42244057 |
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P304 | page(s) | 95 | |
| P577 | publication date | 2010-08-12 | |
| P1433 | published in | BMC Neuroscience | Q15766477 |
| P1476 | title | Proteomic characterization of an isolated fraction of synthetic proteasome inhibitor (PSI)-induced inclusions in PC12 cells might offer clues to aggresomes as a cellular defensive response against proteasome inhibition by PSI. | |
| P478 | volume | 11 | |